TimesSquare Capital Management LLC cut its position in Surgery Partners Inc (NASDAQ:SGRY) by 9.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,381,500 shares of the company’s stock after selling 141,400 shares during the quarter. TimesSquare Capital Management LLC’s holdings in Surgery Partners were worth $16,716,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of SGRY. BlackRock Inc. increased its position in Surgery Partners by 0.5% during the 4th quarter. BlackRock Inc. now owns 1,306,021 shares of the company’s stock worth $15,804,000 after purchasing an additional 7,029 shares in the last quarter. Royal Bank of Canada increased its position in Surgery Partners by 680.5% during the 2nd quarter. Royal Bank of Canada now owns 10,544 shares of the company’s stock worth $240,000 after purchasing an additional 9,193 shares in the last quarter. Voya Investment Management LLC acquired a new position in Surgery Partners during the 2nd quarter worth approximately $222,000. Citadel Advisors LLC acquired a new position in Surgery Partners during the 3rd quarter worth approximately $129,000. Finally, BlueCrest Capital Management Ltd acquired a new position in Surgery Partners during the 4th quarter worth approximately $157,000.
Surgery Partners Inc (SGRY) opened at $17.30 on Monday. The company has a debt-to-equity ratio of 1.56, a current ratio of 2.09 and a quick ratio of 1.92. Surgery Partners Inc has a 12-month low of $7.10 and a 12-month high of $24.05.
Surgery Partners declared that its Board of Directors has initiated a stock buyback plan on Friday, December 15th that allows the company to repurchase $50.00 million in shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.
SGRY has been the subject of a number of research analyst reports. ValuEngine cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. BidaskClub upgraded shares of Surgery Partners from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. Zacks Investment Research cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Thursday, January 25th. Jefferies Group set a $18.00 price objective on shares of Surgery Partners and gave the stock a “buy” rating in a research report on Thursday, March 1st. Finally, Benchmark set a $19.00 price objective on shares of Surgery Partners and gave the stock a “buy” rating in a research report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $18.57.
Surgery Partners Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners Inc (NASDAQ:SGRY).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.